BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19652429)

  • 1. Acromegaly associated with multiple tumors.
    Sekizawa N; Hayakawa E; Tsuchiya K; Yoshimoto T; Akashi T; Fujii T; Yamada S; Hirata Y
    Intern Med; 2009; 48(15):1273-8. PubMed ID: 19652429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
    Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed pituitary adenoma and gangliocytoma associated with acromegaly--case report.
    Asada H; Otani M; Furuhata S; Inoue H; Toya S; Ogawa Y
    Neurol Med Chir (Tokyo); 1990 Aug; 30(8):628-32. PubMed ID: 1703643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly-controlled acromegaly accompanied by subclinical adrenal Cushing's syndrome after surgery for multiple endocrine tumors.
    Ishikawa M; Kato M; Sasaki H; Morii T; Fujita H; Kakei M; Narita T; Yamada Y
    Intern Med; 2015; 54(6):617-20. PubMed ID: 25786452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly associated with GIST, non-small cell lung carcinoma, clear cell renal carcinoma, multiple myeloma, medulla oblongata tumour, adrenal adenoma, and follicular thyroid nodules.
    Jawiarczyk-Przybyłowska A; Wojtczak B; Whitworth J; Sutkowski K; Bidlingmaier M; Korbonits M; Bolanowski M
    Endokrynol Pol; 2019; 70(2):213-217. PubMed ID: 30742299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.
    Hozumi K; Fukuoka H; Odake Y; Takeuchi T; Uehara T; Sato T; Inoshita N; Yoshida K; Matsumoto R; Bando H; Hirota Y; Iguchi G; Taniguchi M; Otsuki N; Nishigori C; Kosaki K; Hasegawa T; Ogawa W; Takahashi Y
    Endocr J; 2019 Oct; 66(10):853-857. PubMed ID: 31189769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal adenocarcinoma with neuroendocrine features in a patient with acromegaly and thyroid papillary adenocarcinoma: a unique combination of endocrine neoplasia.
    Kato K; Takeshita Y; Misu H; Ishikura K; Kakinoki K; Sawada-Kitamura S; Kaneko S; Takamura T
    Endocr J; 2012; 59(9):791-6. PubMed ID: 22673565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone-secreting metastasis detected by 111-indium pentetreotide scan.
    Greenman Y; Woolf P; Coniglio J; O'Mara R; Pei L; Said JW; Melmed S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1628-33. PubMed ID: 8636379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of cDNAs for hormones and/or receptors of growth hormone, insulin-like growth factor-I, thyroid hormone, and corticosteroid and the gender-, tissue-, and developmental-specific expression of their mRNA transcripts in fathead minnow (Pimephales promelas).
    Filby AL; Tyler CR
    Gen Comp Endocrinol; 2007 Jan; 150(1):151-63. PubMed ID: 16970945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of growth hormone hypersecretion on the adult human kidney.
    Grunenwald S; Tack I; Chauveau D; Bennet A; Caron P
    Ann Endocrinol (Paris); 2011 Dec; 72(6):485-95. PubMed ID: 22098791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma.
    Wang XL; Dou JT; Lü ZH; Zhong WW; Ba JM; Jin D; Lu JM; Pan CY; Mu YM
    Chin Med J (Engl); 2011 Nov; 124(22):3820-3. PubMed ID: 22340248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
    Kreutzer J; Vance ML; Lopes MB; Laws ER
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
    Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
    Gradiser M; Matovinovic M; Vrkljan M
    Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.